PGNY News and Press, Progyny Inc. From 08/12/22

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund was down 18.60% (Institutional Shares) in the second quarter 2022. The economy is slowing, as we...

Progyny, Inc. (PGNY) Q2 2022 Earnings Conference Call August 4, 2022 04:45 PM ET Company Participants James Hart - Vice President of Investor Relations Peter Anevski - Chief Executive Officer Michael Sturmer - President Mark Livingston - Chief Financial Offic...

More companies in the U.S. are offering fertility benefits to employees to attract/retain talent and advance the diversity, equity, and inclusion agenda. PGNY has singled itself out as a pure-play fertility benefits management company, building an enviable client roster with 273 clien...

Gainers: Cooper-Standard Holdings ( CPS ) +78% . Highway Holdings ( HIHO ) +62% . Pineapple Energy ( PEGY ) +53% . Intelligent Living ( ILAG ) +55% . Progyny ( PGNY ) +41% . Global Blood Therapeutics ( GBT ) +38% . ...

Gainers: Allied Healthcare Products ( AHPI ) +30% . Progyny ( PGNY ) +28% . Kazia Therapeutics ( KZIA ) +21% . Selecta Biosciences ( SELB ) +18% . Sensus Healthcare ( SRTS ) +17% . Losers: Quoin Pharmaceuticals ( QNRX...

Progyny ( PGNY ) is trading ~18% higher post market after reporting a beat in Q2 consensus and raising the lower end of FY22 guidance. PGNY's Q2 GAAP EPS of $0.09 beats by $0.05 and revenue of $195M (+51.6% Y/Y) beats by $4.49M. The increase is primarily a resu...

Reports Record Quarterly Revenue of $195.0 Million, Reflecting 52% Growth Over the Prior Year Period Seeing Strong Employer Demand for Fertility and Family Building Benefit Solutions Raises Lower End of Full Year 2022 Guidance Ranges Issues Revenue Guidance of $190.0 to $197.0 Million...

NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Progyny is the first, and only, fertility benefits solution to publicly publish its clinical...

NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended June 30, 2022 after the close of the market on T...

Exposure to disruptors in areas of the market that have derated after a surge in demand during the pandemic, namely consumer technology and e-commerce, weighed on performance in a difficult quarter for higher growth stocks. We were active during the quarter, tactically pivoting the po...